national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference



Overview | Agenda/Faculty Materials | Log In | Promotional Opportunities | Sponsors & Exhibitors
Speaking Proposals | Administration | Past Events | Contact Us | Home



THE FOURTH NATIONAL DISCLOSURE SUMMIT CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The Fourth National Disclosure Summit conference content is now available in a variety of formats.

You may purchase the Summit streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE FOURTH NATIONAL DISCLOSURE SUMMIT CONTENT AS FOLLOWS:

Online Archive of 2012 Fourth National Disclosure Summit Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2012 Fourth National Disclosure Summit Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE THE FOURTH NATIONAL DISCLOSURE SUMMIT INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).





national pharmaceutical and medical device disclosure and transparency conference

FOURTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

March 26 - 28, 2012

Onsite:
Renaissance Hotel, Washington, DC


Online:
Live and Archived for 6 Months

GRANTORS
DIAMOND
GOLD

SILVER
BRONZE
























MEDIA PARTNERS

KEYNOTE ADDRESSES
On the Proposed CMS Sunshine Rule:

Niall Brennan, MPP
Acting Director, Policy and Data Analysis Group, Centers for Medicare and Medicaid Services, Washington, DC

On the Role of the OIG:

Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, Department of Health and Human Services, Washington, DC

FEATURING PRECONFERENCE ON SUNSHINE ACT, AGGREGATE SPEND AND DISCLOSURE 101
PLENARY SESSIONS ON
  • The Continuing Role of Congress in Sunshine Act Implementation
  • Drug Samples, the Next Horizon?
  • Inconsistencies between the Sunshine Act, Anti-Kickback, and Medicare and Medicaid Reporting Obligations
  • Lessons Learned from Going Live: Experience of the First Quarter under Sunshine
  • After Sunshine: Deal with the Consequences of Public Disclosures
  • Where Disclosure Meets Enforcement
  • Aggregate Spend Awareness: Physician Survey Results and Case Study
  • Educating Physicians about the Sunshine Law
  • Panel on Global Transparency
  • Coordination of Sunshine Act and Global Disclosure and Transparency Initiatives
  • Case Study: Purdue Aggregate Spend Approach and Solutions
  • Case Study: Sanofi-Aventis Aggregate Spend Approach and Solutions
  • THE FOLLOWING MINI SUMMITS
  • Key Operations Considerations
  • Technology Solutions
  • Sunshine Compliance for Medical Device Companies
  • Research & Development Compliance
  • AND A CLOSING ADVANCED ISSUES BEST
    PRACTICE WORKSHOP




    FOURTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
    AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

    A Pharma Congress Conference
    March 26 - 28, 2012

    ONSITE
    Renaissance Hotel
    Washington, DC


    OR
    ONLINE
    In your own office or home live via the Internet
    with 24/7 access for six months


    CO CHAIRS

    Karen Lowney
    Senior Director, Compliance, Teva Pharmaceuticals, Frazer, PA

    Katherine E. Norris, MPA
    Director, Corporate Compliance, The Spectranetics Corporation, Colorado Springs, CO

    Trudy J. Seeley
    Senior Manager, Transparency Operations, Sanofi US, Bridgewater, NJ
    FEATURED FACULTY

    Danielle Bacco
    Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT

    Michael Bell, Esq.
    President, R-Squared, Princeton, NJ




    Jean Bicknell
    Consultant, Regulatory Law, Baxter Healthcare, Deerfield, IL

    Christine N. Bradshaw, Esq.
    Director, Regulatory and Compliance Services, Porzio Pharmaceutical Services, Associate, Porzio, Bromberg & Newman, Morristown, NJ

    Antoinette Brock
    Director, Business Projects and Planning Bristol-Myers Squibb Philadelphia, PA

    William E. Buzzeo, MS
    Vice President and General Manager Compliance Solutions Division, Cegedim Relationship Management, Richmond, VA

    Ben Carmel
    Manager, Polaris Management Partners, New York, NY

    Louise Cashman
    Senior Manager, HCP Reporting and Analysis, Boston Scientific Corporation, Boston, MA

    Jennifer Colapietro
    Partner, Transparency and Aggregate Spend Practice Lead, PricewaterhouseCoopers LLP, Florham Park, NJ



    Rebecca Crews
    Director Global Compliance, GE Healthcare, Wauwatosa, WI

    Meenakshi Datta, Esq.
    Partner, Sidley Austin LLP, Chicago, IL

    Marc Eigner, MS, MBA
    Partner, Polaris Management Partners, New York, NY

    Mark Farrar
    Associate Director, Navigant Consulting, Atlanta, GA

    Judy Fox
    Director, US Commercial Compliance, Reporting and Sample Accountability, Compliance Implementation Services, Media, PA

    Virginia "Ginny" A. Gibson, Esq.
    Partner, Hogan Lovells US LLP, Former Executive Assistant US Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

    Sarah K. Giesting, Esq.
    Associate, Pharmaceutical Industry Health Regulatory Practice Group, Epstein Becker & Green, New York, NY

    Jeffrey L. Handwerker, Esq.
    Partner, Arnold & Porter, Washington, DC

    John B. Knighton, Esq.
    Director and Interim Chief Compliance Officer, Wright Medical Technology, Inc., Arlington, TN

    Keith M. Korenchuk, JD, MPH
    Partner, Arnold & Porter, Washington, DC

    Daniel A. Kracov, Esq.
    Partner and Chair, FDA and Healthcare Practice, Arnold & Porter, Washington, DC

    Mark Linver
    Managing Director, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, New York, NY

    Seth H. Lundy, Esq.
    Partner and Deputy Chair, FDA and Life Sciences Practice Group, King & Spalding LLP, Washington, DC

    Marilyn May, Esq.
    Senior Litigation Counsel, US Attorney's Office, Eastern District of Pennsylvania, United States Department of Justice, Philadelphia, PA

    Kate Whelley McCabe, Esq.
    Assistant Attorney General, Public Protection Division, Vermont Office of the Attorney General, Montpelier, VT

    Jack Mitchell
    Chief of Oversight and Investigations, Special Committee on Aging, United States Senate, Former Director, Commissioner's Office of Special Investigations, US Food and Drug Administration, Washington, DC

    Una Nash
    Assoc. Director, Compliance and Ethics,Transparency and Disclosure, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, NJ

    MaryAnn Northrup, MSN
    Associate Director, Navigant Consulting, Indianapolis, IN

    John Patrick Oroho, Esq.
    Executive Vice President and Chief Strategy Officer, Porzio Pharmaceutical Services, LLC; Principal, Porzio, Bromberg & Newman PC, Morristown, NJ

    Amy Papranec, MBA
    Vice President, Transparency, Stryker Corporation, Chicago, IL

    Suj Patel
    Director, Life Sciences Practice, Huron Consulting Group, New York, NY

    Marjorie E. Powell, Esq.
    Senior Assistant General Counsel, Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, DC

    Kelly N. (Nikki) Reeves, Esq.
    Partner, King & Spalding, Washington, DC

    Tim Robinson, Esq.
    President, The Regulatory Law Group, PLLC, Executive Vice President & General Counsel, MMIS, Inc., New York, NY

    Jack T. Tanselle
    Managing Director, Navigant Consulting, Inc., Indianapolis, IN

    Manny Tzavlakis
    Managing Director, Life Sciences Practice, Huron Consulting Group, New York, NY

    Brian Welch
    Deputy Compliance Officer, Mylan Inc., Canonsburg, PA

    Jon Wilkenfeld, MBA
    President, Potomac River Partners, Vienna, VA

    Julie Wind
    Director - Physician Payment Reporting, Eli Lilly and Company, Indianapolis, IN

    David Wysocky
    Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers, Florham Park, NJ

    Kim Zahan, MBA
    Director R&D Financial Compliance, GlaxoSmithKline, King of Prussia, PA
    ATTENDANCE OPTIONS
    TRADITIONAL CONFERENCE ATTENDANCE
    By attending onsite, you will be able to more completely immerse in the subject matter, get professional networking opportunities, and interact with the faculty. Register for Preconference and/or Conference.

    LIVE AND ARCHIVED INTERNET ATTENDANCE
    Watch the conference plenary session in live streaming video and listen to streaming audio of track sessions over the Internet and at your convenience at any time 24/7 for the six months following the event.

    The archived conference includes speaker videos and coordinated PowerPoint presentations.

    Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office

    INTERNET INTERFACE SAMPLE

    Click here for a sample stream





    SAVE THE DATE
    SIXTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
    A Hybrid Conference and Internet Event
    May 14 - 16, 2012
    Hilton Budapest
    Budapest, Hungary
    www.InternationalPharmaCongress.com

    SECOND ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS
    A Hybrid Conference and Internet Event
    Sponsored by Pharmaceutical Compliance Forum and Asia Pacific Healthcare Industry Compliance Team
    September 11 - 13, 2012
    Intercontinental Shanghai Pudong Hotel
    Shanghai, China
    www.AsianPharmaCongress.com

    FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
    A Hybrid Conference and Internet Event
    Sponsored by Pharmaceutical Compliance Forum and Latin American Ethics and Compliance Network
    October 2 - 4, 2012
    Hilton Sao Paolo Morumba
    Sao Paulo, Brazil
    www.LatinAmericanPharmaCongress.com

    THIRTEENTH PHARMACEUTICAL REGULATORY
    AND COMPLIANCE CONGRESS

    Sponsored by Pharmaceutical Compliance Forum
    November 5 - 7, 2012
    Grand Hyatt
    Washington, DC
    www.PharmaCongress.com


    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.




    Overview | Agenda/Faculty Materials | Log In | Promotional Opportunities | Sponsors & Exhibitors
    Speaking Proposals | Administration | Past Events | Contact Us | Home




    © Health Care Conference Administrators
    Contact Webmaster
    line_horiz.gif" BORDER=0 WIDTH=100% HEIGHT=1>


    © Health Care Conference Administrators
    Contact Webmaster